Corvus Pharmaceuticals (NASDAQ:CRVS) Share Price Passes Abov

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.43 and traded as high as $1.54. Corvus Pharmaceuticals shares last traded at $1.51, with a volume of 105,012 shares traded. Analyst Ratings Changes A number […]

Related Keywords

, Nasdaq , Corvus Pharmaceuticals , Charles Schwab Investment Management Inc , Cantor Fitzgerald , Tower Research Capital , Institutional Trading Of Corvus Pharmaceuticals , Corvus Pharmaceuticals Company Profile , York Mellon Corp , Corvus Pharmaceuticals Price Performance , Virtu Financial , Tucker Asset Management , Corvus Pharmaceuticals Inc , News Ratings For Corvus Pharmaceuticals Daily , Get Free Report , Asset Management , Schwab Investment Management , Research Capital , New York Mellon Corp , Corvus Pharmaceuticals Daily , Nasdaq Crvs , Ccrvs , Medical , Stocks , Technicals ,